Trilaciclib use for prevention of hematological adverse events in chemotherapy: A meta-analysis of real-world studies and clinical trials.
Nitya Batra(Jacksonville College), Mohammad Muhsin Chisti(Beaumont Hospital, Troy), Vikash Jaiswal(Unknown), Z. Alnabulsi(Beaumont Hospital, Royal Oak), Morgan Kiryakoza, Abhigan Babu Shrestha(Dinajpur Medical College), Atulya Aman Khosla(Baptist Hospital of Miami)
Cited by 0
Related Papers
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80
COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review
|Journal of Primary Care & Community Health|2021|48
Diagnostic potential of multi‐targeted LAMP (loop‐mediated isothermal amplification) for osteoarticular tuberculosis
|Journal of Orthopaedic Research®|2016|44
Depression and Its Effect on the Menstrual Cycle
|Cureus|2021|43